TGM2 and celiac disease: The presence of coeliac disease in our cohort is in line with previously published Swedish point prevalence in JIA of 2.8% by Öman, et al. In their study, they screened JIA patients with autoantibodies against tissue transglutaminase and confirmed the diagnosis with small intestine biopsies.